Federal contractor · FORT COLLINS, CO

ARMIS BIOPHARMA, INC.

No contract obligations recorded for ARMIS BIOPHARMA, INC. in FY2026. Since FY2023: $4.8M.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
WMR2HDJ79576
Small business

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 2.4MFY2023
  2. 2.4MFY2024
  3. 0FY2025

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for ARMIS BIOPHARMA, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

ARMIS BIOPHARMA, INC. received $0 in federal assistance in FY2026, on 0 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
0
Since FY2021
$655K

Assistance by fiscal year

  1. 271.4KFY2021
  2. 526.9KFY2022
  3. 858.4KFY2023
  4. 0FY2024
  5. -1MFY2025

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2025.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. SYNERGENE THERAPEUTICS INC$2.3M−100% in FY2026
    POTOMAC, MD · 97% of this company's obligations are in markets they both serveDefense Threat Reduction Agency · Scientific research and development services
  2. OCCAM'S RAZOR TECHNOLOGIES LLC$2.6M−103% in FY2026
    RESTON, VA · 100% of this company's obligations are in markets they both serveDefense Threat Reduction Agency · Scientific research and development services
  3. PARABON NANOLABS, INC.$2.7M−99% in FY2026
    RESTON, VA · 98% of this company's obligations are in markets they both serveDefense Threat Reduction Agency · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.